FHTX
Price
$4.46
Change
-$0.22 (-4.70%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
235.8M
18 days until earnings call
RLAY
Price
$3.08
Change
-$0.03 (-0.96%)
Updated
Apr 24, 02:46 PM (EDT)
Capitalization
496.7M
7 days until earnings call
Ad is loading...

FHTX vs RLAY

Header iconFHTX vs RLAY Comparison
Open Charts FHTX vs RLAYBanner chart's image
Foghorn Therapeutics
Price$4.46
Change-$0.22 (-4.70%)
Volume$1.66K
Capitalization235.8M
Relay Therapeutics
Price$3.08
Change-$0.03 (-0.96%)
Volume$800
Capitalization496.7M
FHTX vs RLAY Comparison Chart
Loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FHTX vs. RLAY commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Buy and RLAY is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (FHTX: $4.68 vs. RLAY: $3.11)
Brand notoriety: FHTX and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 168% vs. RLAY: 99%
Market capitalization -- FHTX: $235.8M vs. RLAY: $496.7M
FHTX [@Biotechnology] is valued at $235.8M. RLAY’s [@Biotechnology] market capitalization is $496.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 5 TA indicator(s) are bullish while RLAY’s TA Score has 5 bullish TA indicator(s).

  • FHTX’s TA Score: 5 bullish, 4 bearish.
  • RLAY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than FHTX.

Price Growth

FHTX (@Biotechnology) experienced а +34.87% price change this week, while RLAY (@Biotechnology) price change was +19.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -6.02%, and the average quarterly price growth was -12.56%.

Reported Earning Dates

FHTX is expected to report earnings on Aug 12, 2025.

RLAY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($497M) has a higher market cap than FHTX($236M). FHTX YTD gains are higher at: -0.847 vs. RLAY (-24.515). FHTX has higher annual earnings (EBITDA): -97.17M vs. RLAY (-380.21M). RLAY has more cash in the bank: 781M vs. FHTX (244M). FHTX has less debt than RLAY: FHTX (37.1M) vs RLAY (48.5M). FHTX has higher revenues than RLAY: FHTX (22.6M) vs RLAY (10M).
FHTXRLAYFHTX / RLAY
Capitalization236M497M47%
EBITDA-97.17M-380.21M26%
Gain YTD-0.847-24.5153%
P/E RatioN/AN/A-
Revenue22.6M10M226%
Total Cash244M781M31%
Total Debt37.1M48.5M76%
TECHNICAL ANALYSIS
Technical Analysis
FHTXRLAY
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FOSBX26.310.29
+1.11%
Tributary Small Company Instl Plus
NEMAX19.92N/A
N/A
Neuberger Berman Emerg Mkts Eq A
MSFRX18.56N/A
N/A
MFS Total Return A
MTCLX59.64N/A
N/A
MFS Technology R6
LKBLX50.46N/A
N/A
LK Balanced Institutional

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with NAUT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then NAUT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+10.38%
NAUT - FHTX
52%
Loosely correlated
-5.10%
ABOS - FHTX
50%
Loosely correlated
+3.86%
XNCR - FHTX
50%
Loosely correlated
+2.07%
IMNM - FHTX
48%
Loosely correlated
+3.54%
AVIR - FHTX
46%
Loosely correlated
-0.98%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+6.14%
XNCR - RLAY
50%
Loosely correlated
+2.07%
BCYC - RLAY
48%
Loosely correlated
-0.69%
RXRX - RLAY
47%
Loosely correlated
-0.89%
RVMD - RLAY
45%
Loosely correlated
+1.57%
FHTX - RLAY
45%
Loosely correlated
+10.38%
More